TGFB1 and neoplasm: Altogether, these data suggest that eribulin triggers a phenotypic transition from tumor-supportive to tumor-suppressive, which is akin to known TGFβ inhibition for most but not all the tested traits, thus rendering CAF/ECM units with selected features reminiscent of “normalized” CAFs [15, 40].